Adalimumab/golimumab/infliximabCytomegalovirus infection, development of anti-drug antibodies and lack of efficacy: case report

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-021-06787-8
中图分类号
学科分类号
摘要
引用
收藏
页码:28 / 28
相关论文
共 50 条
  • [25] Dose escalation of adalimumab as a strategy to overcome anti-drug antibodies: A case report of infantile-onset inflammatory bowel disease
    Ancona, Silvana
    Signa, Sara
    Longo, Chiara
    Cangemi, Giuliana
    Carfora, Roberta
    Drago, Enrico
    La Rosa, Alessandro
    Crocco, Marco
    Chiaro, Andrea
    Gandullia, Paolo
    Arrigo, Serena
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (38) : 5428 - 5434
  • [26] Immunological cross-reactivity of anti-drug antibodies to adalimumab and ABP 501
    Miller, J.
    Manning, M. Starcevic
    Wala, I.
    Wang, H.
    Krishnan, E.
    Kaliyaperumal, A.
    Zhang, N.
    Mytych, D.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S120 - S120
  • [28] Early Anti-Drug Antibodies Predict Adalimumab Response in Juvenile Idiopathic Arthritis
    Huang, Bo-Han
    Hsu, Jr-Lin
    Huang, Hsin-Yi
    Huang, Jing-Long
    Yeh, Kuo-Wei
    Chen, Li-Chen
    Lee, Wen-, I
    Yao, Tsung-Chieh
    Ou, Liang-Shiou
    Lin, Syh-Jae
    Su, Kuan-Wen
    Wu, Chao-Yi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (03)
  • [29] Development of anti-drug monoclonal antibody panels against adalimumab and infliximab
    Suzuki, Takuo
    Tada, Minoru
    Ishii-Watabe, Akiko
    BIOLOGICALS, 2020, 63 : 39 - 47